• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顶质体非管家功能的抑制剂可抵抗恶性疟原虫的延迟死亡。

Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.

作者信息

Ramya T N C, Mishra Satyendra, Karmodiya Krishanpal, Surolia Namita, Surolia Avadhesha

机构信息

Molecular Biophysics Unit, Indian Institute of Science, Bangalore 560012, India.

出版信息

Antimicrob Agents Chemother. 2007 Jan;51(1):307-16. doi: 10.1128/AAC.00808-06. Epub 2006 Oct 23.

DOI:10.1128/AAC.00808-06
PMID:17060533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1797641/
Abstract

Targeting of apicoplast replication and protein synthesis in the apicomplexan Toxoplasma gondii has conventionally been associated with the typical "delayed death" phenotype, characterized by the death of parasites only in the generation following drug intervention. We demonstrate that antibiotics like clindamycin, chloramphenicol, and tetracycline, inhibitors of prokaryotic protein synthesis, invoke the delayed death phenotype in Plasmodium falciparum, too, as evident from a specific reduction of apicoplast genome copy number. Interestingly, however, molecules like triclosan, cerulenin, fops, and NAS-91, inhibitors of the recently discovered fatty acid synthesis pathway, and succinyl acetone, an inhibitor of heme biosynthesis that operates in the apicoplast of the parasite, display rapid and striking parasiticidal effects. Our results draw a clear distinction between apicoplast functions per se and the apicoplast as the site of metabolic pathways, which are required for parasite survival, and thus subserve the development of novel antimalarial therapy.

摘要

针对顶复门寄生虫刚地弓形虫的顶质体复制和蛋白质合成,传统上一直与典型的“延迟死亡”表型相关,其特征是寄生虫仅在药物干预后的下一代死亡。我们证明,像克林霉素、氯霉素和四环素这样的抗生素,作为原核生物蛋白质合成的抑制剂,在恶性疟原虫中也会引发延迟死亡表型,这从顶质体基因组拷贝数的特异性减少中可以明显看出。然而,有趣的是,像三氯生、铜绿菌素、氟苯丙氨酸和NAS - 91这样的分子,作为最近发现的脂肪酸合成途径的抑制剂,以及琥珀酰丙酮,一种在寄生虫顶质体中起作用的血红素生物合成抑制剂,显示出快速且显著的杀寄生虫作用。我们的结果明确区分了顶质体本身的功能和作为寄生虫生存所需代谢途径位点的顶质体,从而有助于新型抗疟疗法的开发。

相似文献

1
Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum.顶质体非管家功能的抑制剂可抵抗恶性疟原虫的延迟死亡。
Antimicrob Agents Chemother. 2007 Jan;51(1):307-16. doi: 10.1128/AAC.00808-06. Epub 2006 Oct 23.
2
Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics.顶质体的翻译、转录和基因组复制:抗疟抗生素的作用靶点
Trends Parasitol. 2008 Jun;24(6):279-84. doi: 10.1016/j.pt.2008.03.007. Epub 2008 Apr 29.
3
Understanding the biology of the Plasmodium falciparum apicoplast; an excellent target for antimalarial drug development.了解恶性疟原虫质体的生物学特性;这是抗疟药物研发的一个极好靶点。
Life Sci. 2016 Aug 1;158:104-10. doi: 10.1016/j.lfs.2016.06.030. Epub 2016 Jul 2.
4
Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites.利用化学补充测定法在培养的人类疟疾寄生虫中验证潜在的质体靶向药物。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01161-17. Print 2018 Jan.
5
Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy.疟原虫生物化学与抗疟化疗的范式转变
Bioessays. 2002 Feb;24(2):192-6. doi: 10.1002/bies.10042.
6
The apicoplast of Plasmodium falciparum is translationally active.恶性疟原虫的顶质体具有翻译活性。
Mol Microbiol. 2005 Apr;56(1):81-9. doi: 10.1111/j.1365-2958.2005.04538.x.
7
Antimalarial drugs and drug targets specific to fatty acid metabolic pathway of Plasmodium falciparum.抗疟药物及疟原虫脂肪酸代谢途径的药物靶点。
Chem Biol Drug Des. 2012 Aug;80(2):155-72. doi: 10.1111/j.1747-0285.2012.01389.x. Epub 2012 May 28.
8
Delayed death in the malaria parasite Plasmodium falciparum is caused by disruption of prenylation-dependent intracellular trafficking.疟原虫恶性疟原虫中的延迟死亡是由依赖异戊烯化的细胞内运输的破坏引起的。
PLoS Biol. 2019 Jul 18;17(7):e3000376. doi: 10.1371/journal.pbio.3000376. eCollection 2019 Jul.
9
A plastid organelle as a drug target in apicomplexan parasites.质体细胞器作为顶复门寄生虫的药物靶点。
Nature. 1997 Nov 27;390(6658):407-9. doi: 10.1038/37132.
10
Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast.热带传染病:恶性疟原虫顶质体的代谢图谱与功能
Nat Rev Microbiol. 2004 Mar;2(3):203-16. doi: 10.1038/nrmicro843.

引用本文的文献

1
Inner-mitochondrial membrane protein PfMPV17 is linked to P. falciparum in vitro resistance to the indoloquinolizidine alkaloid alstonine.线粒体内膜蛋白PfMPV17与恶性疟原虫对吲哚喹嗪生物碱鸡骨常山碱的体外抗性有关。
J Antimicrob Chemother. 2025 Jul 1;80(7):1869-1877. doi: 10.1093/jac/dkaf141.
2
Apicoplast-Resident Processes: Exploiting the Chink in the Armour of Parasites.顶质体驻留过程:利用寄生虫防护中的薄弱环节
Adv Pharmacol Pharm Sci. 2024 May 10;2024:9940468. doi: 10.1155/2024/9940468. eCollection 2024.
3
Comparative chemical genomics in species identifies the alkaline phosphatase PhoD as a determinant of antiparasitic resistance.物种间比较化学基因组学确定碱性磷酸酶 PhoD 是抗寄生虫抗性的决定因素。
Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2312987121. doi: 10.1073/pnas.2312987121. Epub 2024 Feb 20.
4
Selection of an Aptamer against the Enzyme 1-deoxy-D-xylulose-5-phosphate Reductoisomerase from .从……中筛选针对1-脱氧-D-木酮糖-5-磷酸还原异构酶的适配体
Pharmaceutics. 2022 Nov 19;14(11):2515. doi: 10.3390/pharmaceutics14112515.
5
Critical role for isoprenoids in apicoplast biogenesis by malaria parasites.异戊烯焦磷酸在疟原虫类顶复体生物发生中的关键作用。
Elife. 2022 Mar 8;11:e73208. doi: 10.7554/eLife.73208.
6
Inhibitory Compounds Targeting Plasmodium falciparum Gyrase B.抑制疟原虫拓扑异构酶 B 的化合物
Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0026721. doi: 10.1128/AAC.00267-21. Epub 2021 Aug 2.
7
Doxycycline has distinct apicoplast-specific mechanisms of antimalarial activity.多西环素具有独特的疟原虫apicoplast 特异性抗疟作用机制。
Elife. 2020 Nov 2;9:e60246. doi: 10.7554/eLife.60246.
8
Redesigned TetR-Aptamer System To Control Gene Expression in Plasmodium falciparum.重新设计的 TetR-Aptamer 系统可控制疟原虫中的基因表达。
mSphere. 2020 Aug 12;5(4):e00457-20. doi: 10.1128/mSphere.00457-20.
9
Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials.探究开放全球健康化学多样性文库中的多阶段活性起始点,以开发新一代抗疟药物。
ACS Infect Dis. 2020 Apr 10;6(4):613-628. doi: 10.1021/acsinfecdis.9b00482. Epub 2020 Mar 4.
10
Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.延迟死亡药物治疗的控制性感染免疫可引发针对血期疟原虫的保护性免疫反应。
Infect Immun. 2018 Dec 19;87(1). doi: 10.1128/IAI.00587-18. Print 2019 Jan.

本文引用的文献

1
The plasmodial apicoplast was retained under evolutionary selective pressure to assuage blood stage oxidative stress.
Med Hypotheses. 2005;65(4):683-90. doi: 10.1016/j.mehy.2005.05.011.
2
Redox and antioxidant systems of the malaria parasite Plasmodium falciparum.恶性疟原虫的氧化还原与抗氧化系统
Mol Microbiol. 2004 Sep;53(5):1291-305. doi: 10.1111/j.1365-2958.2004.04257.x.
3
'FAS't inhibition of malaria.“FAS”对疟疾的抑制作用
Biochem J. 2004 Nov 1;383(Pt. 3):401-12. doi: 10.1042/BJ20041051.
4
The human malaria parasite Plasmodium falciparum has distinct organelle-specific lipoylation pathways.人类疟原虫恶性疟原虫具有独特的细胞器特异性脂酰化途径。
Mol Microbiol. 2004 Jul;53(1):103-13. doi: 10.1111/j.1365-2958.2004.04112.x.
5
Tropical infectious diseases: metabolic maps and functions of the Plasmodium falciparum apicoplast.热带传染病:恶性疟原虫顶质体的代谢图谱与功能
Nat Rev Microbiol. 2004 Mar;2(3):203-16. doi: 10.1038/nrmicro843.
6
Identification, characterization, and inhibition of Plasmodium falciparum beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ).恶性疟原虫β-羟酰基-酰基载体蛋白脱水酶(FabZ)的鉴定、表征及抑制
J Biol Chem. 2003 Nov 14;278(46):45661-71. doi: 10.1074/jbc.M304283200. Epub 2003 Aug 20.
7
Fosmidomycin, a novel chemotherapeutic agent for malaria.磷霉素,一种新型抗疟化疗药物。
Antimicrob Agents Chemother. 2003 Feb;47(2):735-8. doi: 10.1128/AAC.47.2.735-738.2003.
8
A type II pathway for fatty acid biosynthesis presents drug targets in Plasmodium falciparum.脂肪酸生物合成的II型途径为恶性疟原虫提供了药物靶点。
Antimicrob Agents Chemother. 2003 Jan;47(1):297-301. doi: 10.1128/AAC.47.1.297-301.2003.
9
The apicoplast as an antimalarial drug target.顶质体作为抗疟药物靶点。
Drug Resist Updat. 2001 Jun;4(3):145-51. doi: 10.1054/drup.2001.0205.
10
Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.恶性疟原虫烯脂酰-ACP还原酶与其底物及抑制剂相互作用的动力学决定因素。
Biochem Biophys Res Commun. 2001 Dec 14;289(4):832-7. doi: 10.1006/bbrc.2001.6061.